⌘K

Home/Filings/4/0000899243-22-000188

4//SEC Filing

Lo Andrew 4

Accession 0000899243-22-000188

CIK 0001743881other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 7:57 PM ET

Size

6.8 KB

Accession

0000899243-22-000188

Insider Transaction Report

Form 4

Period: 2021-12-29

BridgeBio Pharma, Inc.BBIO

Director

Transactions

Purchase
Common Stock
2021-12-29$12.90/sh+6,000$77,400→ 46,599 total
Purchase
Common Stock
2021-12-30$14.30/sh+1,500$21,450→ 48,099 total

Holdings

Common Stock
(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
205,583

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0001679076

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 7:57 PM ET
Size: 6.8 KB

View on SEC.gov